OBJECTIVE： To evaluate clinical efficacy of point application or adjuvant therapy on chronic obstruc- tive pulmonary disease in stationary phase and ef- fects on pulmonary functions. METHODS： Computer retrieved CNKI...OBJECTIVE： To evaluate clinical efficacy of point application or adjuvant therapy on chronic obstruc- tive pulmonary disease in stationary phase and ef- fects on pulmonary functions. METHODS： Computer retrieved CNKI, VIR CBM and other databanks and manual operations retrieved correlative literatures to find randomized con- trolled trials （RCTs） about comparison between point application or adjuvant therapy and no-point-applications for treatment of chronic ob- structive pulmonary disease in stationary phase in China. RevMan 5.0 software was used for Meta anal- ysis. RESULTS： Among 3481 cases in the inclusive 32 RCTS, 1780 cases were in the test group and 1701 cases in the control group. Meta analysis indicated： I） clinical efficacy： the groups containing point ap- plication therapy all were better than the groups ofno-point-application; 2） force vital capacity （FVC）： There was no statistically significant difference be- tween the group of point application plus Western Medicine and the Western Medicine group; 3） force expiratory volume 1 （FEVl）： The groups containing point application therapy were better than the no-point-application; 4） FEV1% ： the groups of point application plus Western Medicine were bet- ter than the Western Medicine groups; 5） FEVl/FVC： there was a significant difference between the group of point application plus Chinese drugs and the group of Chinese drug. CONCLUSION： Point application can increase clini- cal efficacy of chronic obstructive pulmonary dis- ease in stationary phase in varying degrees, and dif- ferent combinations of point application with Chi- nese drugs or Western Medicines have incomplete same actions in improvement of pulmonary func- tion and therapeutic effect.展开更多
文摘OBJECTIVE： To evaluate clinical efficacy of point application or adjuvant therapy on chronic obstruc- tive pulmonary disease in stationary phase and ef- fects on pulmonary functions. METHODS： Computer retrieved CNKI, VIR CBM and other databanks and manual operations retrieved correlative literatures to find randomized con- trolled trials （RCTs） about comparison between point application or adjuvant therapy and no-point-applications for treatment of chronic ob- structive pulmonary disease in stationary phase in China. RevMan 5.0 software was used for Meta anal- ysis. RESULTS： Among 3481 cases in the inclusive 32 RCTS, 1780 cases were in the test group and 1701 cases in the control group. Meta analysis indicated： I） clinical efficacy： the groups containing point ap- plication therapy all were better than the groups ofno-point-application; 2） force vital capacity （FVC）： There was no statistically significant difference be- tween the group of point application plus Western Medicine and the Western Medicine group; 3） force expiratory volume 1 （FEVl）： The groups containing point application therapy were better than the no-point-application; 4） FEV1% ： the groups of point application plus Western Medicine were bet- ter than the Western Medicine groups; 5） FEVl/FVC： there was a significant difference between the group of point application plus Chinese drugs and the group of Chinese drug. CONCLUSION： Point application can increase clini- cal efficacy of chronic obstructive pulmonary dis- ease in stationary phase in varying degrees, and dif- ferent combinations of point application with Chi- nese drugs or Western Medicines have incomplete same actions in improvement of pulmonary func- tion and therapeutic effect.
